C2N Diagnostics has received a $10m strategic investment out of Samsung’s life science investment fund. The US company said ...

In their view, inorganic molecules might have reacted due to energy from the Sun or lightning strikes to form life’s building ...

We all know someone who seems to defy aging—people who look younger than their peers despite being the same age. What's their ...

In this interview, we spoke with Lee Ferguson of Duke University about his laboratory’s work accurately tracing these ...

Researchers from Swansea University and King’s College London are working to eradicate potholes from our modern ...

About two-thirds of us have it in our bodies, but for most people, the bacterium Helicobacter pylori (H. pylori for short) ...

Researchers have unveiled the first real look at a mitochondrial protein strongly linked to Parkinson's disease, revealing ...

A research group has developed an improved workflow for constructing machine learning (ML) models in oligonucleotide ...

Thermo Fisher is among the industry's best when it comes to cost control. As near-term spending is constrained, the company's margins show exceptional resilience. As of fiscal year-end 2024, Thermo ...

Discover groundbreaking research on how algae are accelerating the melting of Greenland’s ice sheet. Learn about the ...

Inficon Holding AG (XSWX:IFCN) reports record sales in multiple sectors, strategic R&D investments, and a proposed share split to enhance market liquidity.

C2N Diagnostics, LLC, a specialty diagnostics company, has received a $10 million investment from Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis, and Samsung Venture Investment ...